✦ LIBER ✦

Sclerostin antibody improves skeletal parameters in a Brtl/+ mouse model of osteogenesis imperfecta

✍ Scribed by Sinder, Benjamin P; Eddy, Mary M; Ominsky, Michael S; Caird, Michelle S; Marini, Joan C; Kozloff, Kenneth M

Book ID: 118762384
Publisher: American Society for Bone and Mineral Research
Year: 2012
Tongue: English
Weight: 766 KB
Volume: 28
Category: Article
ISSN: 0884-0431
DOI: 10.1002/jbmr.1717

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Nanoscale morphology of Type I collagen

Nanoscale morphology of Type I collagen is altered in the Brtl mouse model of Osteogenesis Imperfecta

✍ Joseph M. Wallace; Bradford G. Orr; Joan C. Marini; Mark M. Banaszak Holl 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 949 KB

Growth Hormone Injections Improve Bone Q

Growth Hormone Injections Improve Bone Quality in a Mouse Model of Osteogenesis Imperfecta

✍ Donna King; David Jarjoura; Heather A McEwen; Michael J Askew 📂 Article 📅 2005 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 107 KB

A Controlled Study of the Effects of Ale

A Controlled Study of the Effects of Alendronate in a Growing Mouse Model of Osteogenesis Imperfecta

✍ N.P. Camacho; C.L. Raggio; S.B. Doty; L. Root; V. Zraick; W.A. Ilg; T.R. Toledan 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 313 KB

Use of marrow stromal cells to replace b

Use of marrow stromal cells to replace bone cells in a transgenic mouse model for osteogenesis imperfecta

✍ Ruth F. Pereira; Kenneth W. Halford; Michael D. O'Hara; Marea D. Polland; Patric 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 97 KB

The effects of RANKL inhibition on fract

The effects of RANKL inhibition on fracture healing and bone strength in a mouse model of osteogenesis imperfecta

✍ Demetris Delos; Xu Yang; Benjamin F. Ricciardi; Elizabeth R. Myers; Mathias P.G. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 387 KB 👁 1 views

## Abstract Currently, the standard treatment for osteogenesis imperfecta (OI) is bisphosphonate therapy. Recent studies, however, have shown delayed healing of osteotomies in a subset of OI patients treated with such agents. The current study sought to determine the effects of another therapy, RAN

Abnormal type I collagen folding and mat

Abnormal type I collagen folding and matrix deposition in a cyclophilin B KO mouse model of recessive osteogenesis imperfecta

✍ W.A. Cabral⁎; A.M. Barnes; E. Makareeva; M. Weis; W. Chang; S. Leikin; D.R. Eyre 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 68 KB